StonvexLoading…
StonvexStonvexStonvexCore line items from TSBK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Annual 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $53.15M | $27.20M | $102.28M | $25.54M |
Operating Income | Not available | Not available | Not available | Not available |
Net Income | $15.35M | $8.22M | $29.16M | $7.10M |
EPS (Diluted) | $1.94 | $1.04 | $3.67 | $0.90 |
Total Assets | $2.05B | $2.01B | $2.01B | $1.96B |
Total Liabilities | $1.78B | $1.74B | $1.75B | $1.70B |
Cash & Equivalents | $294.67M | $246.86M | $243.43M | $193.63M |
Free Cash Flow OCF − CapEx | $11.83M | $5.58M | $28.42M | $18.94M |
Shares Outstanding | 7.83M | 7.88M | 7.89M | 7.88M |